Atlas Spine
PrivateLast Round
Series B
Apr 8, 2015
Total Funding Raised
$3.74M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Atlas Spine is a surgical devices company that creates, manufactures, and markets minimally invasive implants and instrument systems for the treatment of various pathologies of the spine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atlas Spine Comparables
Compare Atlas Spine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wenzel Spine, Inc. | 88% | |
| Life Spine, Inc. | 88% | |
| Spineology | 88% | |
Atlas Spine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 8, 2015 | ||||
| Series A | Mar 18, 2011 | ||||
| Grant | Nov 3, 2010 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 55% MoM, reaching 2.8K.
- May 1, 2025
Monthly visitors grew 129% MoM, reaching 1.8K.
Atlas Spine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atlas Spine's valuation, stock price, and market status.